Intravaginal dehydroepiandrosterone for genitourinary symptoms of the menopause: Is the evidence sufficient?
Sign Up to like & getrecommendations! Published in 2022 at "Post Reproductive Health"
DOI: 10.1177/20533691221135906
Abstract: Intravaginal dehydroepiandrosterone (DHEA) is a locally metabolised estrogen and androgen precursor, licensed in 2018 in the EU for moderate to severe vulvovaginal atrophy in postmenopausal women. A literature search revealed four original trials suitable for… read more here.
Keywords: dyspareunia; dehydroepiandrosterone genitourinary; dehydroepiandrosterone; genitourinary symptoms ... See more keywords